Axogen, Inc.
43.44USD
-3.8300 (-8.11%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 70 | 61 | 60 | 60 | 57 | 49 | 49 | 49 |
| Cost of Revenue | 19 | 15 | 15 | 14 | 15 | 14 | 12 | 12 |
| Gross Profit | 51 | 46 | 44 | 46 | 42 | 35 | 38 | 36 |
| Operating Income | -2 | -3 | -10 | 2 | 2 | -2 | 2 | -0 |
| Net Income | -2 | -20 | -13 | 1 | 1 | -4 | 0 | -2 |
| EPS (Diluted) | $-0.03 | $-0.38 | $-0.28 | $0.01 | $0.01 | $-0.08 | $0.01 | $-0.04 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)